Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis-Reference-Cited by-同舟云学术

Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis

Published:2014-03 Issue:3 Volume:20 Page:155-158
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Thakur Akanksha,Witteles Ronald M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. The diagnosis and management of cardiovascular disease in patients with cancer;Yeh,2011

2. Cardioprotective Interventions for cancer patients receiving anthracyclines;van Dalen;Cochrane Database Syst Rev,2008

3. The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients;Hall;J Am Coll Cardiol Heart Fail,2013

4. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer;Ryberg;J Clin Onc,1998

5. Risk factors for doxorubicin-induced congestive heart failure;von Hoff;Am J Med,1977

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure related to contemporary breast cancer treatment;JAAPA;2024-03-26

2. Effect of variable left ventricular ejection fraction assessed by equilibrium radionuclide angiocardiography using different software packages on the diagnosis of cardiotoxicity in patients with cancer;Journal of Nuclear Cardiology;2024-01

3. Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma;Biomedicines;2023-01-11

4. Early echocardiographic alterations in cancer patients during chemotherapy;Russian Journal of Cardiology;2022-12-07

5. Cellular and Molecular Mechanisms of MEK1 Inhibitor–Induced Cardiotoxicity;JACC: CardioOncology;2022-11